Cargando…

Tapentadol and Oxycodone/Naloxone Prescribing Patterns in Primary Health Care in Catalonia, Spain: A Cross-Sectional Study

OBJECTIVE: To characterize the use of tapentadol and the combination oxycodone/naloxone in primary health care. Data on their use and possible misuse will allow the identification of risk factors and to design protocols to reduce and prevent avoidable harm to patients being treated for pain. DESIGN:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viñas-Bastart, Montserrat, Oms-Arias, Míriam, Pedraza-Gutiérrez, Àfrica, Lizano-Díez, Irene, Mariño, Eduardo L, Modamio, Pilar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500723/ https://www.ncbi.nlm.nih.gov/pubmed/34675710 http://dx.doi.org/10.2147/RMHP.S301724

Ejemplares similares

Profile, cost and pattern of prescriptions for polymedicated patients in Catalonia, Spain
por: Lizano-Díez, Irene, et al.
Publicado: (2013)

Evaluation of electronic prescription implementation in polymedicated users of Catalonia, Spain: a population-based longitudinal study
por: Lizano-Díez, Irene, et al.
Publicado: (2014)

Methodological Issues on a Clinical Trial to Test Tapentadol Prolonged release vs. Oxycodone/Naloxone Prolonged release
por: Bacallao, Jorge, et al.
Publicado: (2016)

Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study
por: Barrachina, Jordi, et al.
Publicado: (2022)

Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study
por: Barrachina, Jordi, et al.
Publicado: (2022)

Tapentadol vs oxycodone/naloxone in the management of pain after total hip arthroplasty in the fast track setting: an observational study
por: D’Amato, Tiziana, et al.
Publicado: (2019)

Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone
por: Haeseler, Gertrud, et al.
Publicado: (2017)

The place of oxycodone/naloxone in chronic pain management
por: Leppert, Wojciech
Publicado: (2013)

Tapentadol shows lower intrinsic efficacy at µ receptor than morphine and oxycodone
por: Manandhar, Preeti, et al.
Publicado: (2022)

Gluten in pharmaceutical products: a scoping review
por: Lizano-Díez, Irene, et al.
Publicado: (2021)

Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR
por: Durkin, Mike, et al.
Publicado: (2015)

Effects of the Off-Label Drug Prescription in the Paediatric Population in Spain from the Adoption of the Latest European Regulation: A Pre-Post Study
por: Lizano-Díez, Irene, et al.
Publicado: (2021)

Breast cancer incidence and overdiagnosis in Catalonia (Spain)
por: Martinez-Alonso, Montserrat, et al.
Publicado: (2010)

Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment
por: Kokki, Merja, et al.
Publicado: (2016)

Treatment of Opioid Withdrawal Syndrome Triggered by Oxycodone/Naloxone with Dexmedetomidine
por: Go, Se-Il, et al.
Publicado: (2023)

Web-Based Discussion and Illicit Street Sales of Tapentadol and Oxycodone in Australia: Epidemiological Surveillance Study
por: Black, Joshua, et al.
Publicado: (2021)

Dissemination of periodic mammography and patterns of use, by birth cohort, in Catalonia (Spain)
por: Rue, Montserrat, et al.
Publicado: (2008)

Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis
por: Lazzari, Marzia, et al.
Publicado: (2015)

Colorectal Transit and Volume During Treatment With Prolonged-release Oxycodone/Naloxone Versus Oxycodone Plus Macrogol 3350
por: Poulsen, Jakob L, et al.
Publicado: (2018)

Epidemiology of foodborne Norovirus outbreaks in Catalonia, Spain
por: Martinez, Ana, et al.
Publicado: (2008)

Influence of tapentadol and oxycodone on the spinal cord and brain using electrophysiology: a randomized, placebo‐controlled trial
por: Nedergaard, Rasmus Bach, et al.
Publicado: (2022)

Pain therapy with oxycodone/naloxone prolonged-release combination: case report
por: Błaszczyk, Feliks, et al.
Publicado: (2013)

Intractable restless legs syndrome: role of prolonged-release oxycodone–naloxone
por: de Biase, Stefano, et al.
Publicado: (2016)

Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice
por: Ueberall, Michael A, et al.
Publicado: (2016)

Comparison of the Risks of Shopping Behavior and Opioid Abuse Between Tapentadol and Oxycodone and Association of Shopping Behavior and Opioid Abuse
por: Cepeda, M. Soledad, et al.
Publicado: (2014)

Prescribing trend of tapentadol in a Sydney local health district
por: Mirabella, Jennifer, et al.
Publicado: (2022)

Abuse Potential of Intravenous Oxycodone/Naloxone Solution in Nondependent Recreational Drug Users
por: Colucci, Salvatore V., et al.
Publicado: (2014)

Combined Administration of Oxycodone/Naloxone in Chronic Osteo-Articular Diseases Pain Therapy
por: Rosa, Palomba, et al.
Publicado: (2014)

Developments in managing severe chronic pain: role of oxycodone–naloxone extended release
por: Fanelli, Guido, et al.
Publicado: (2015)

Outcomes Associated with Treatment of Chronic Pain with Tapentadol Compared with Morphine and Oxycodone: A UK Primary Care Observational Study
por: Morgan, Christopher Ll., et al.
Publicado: (2019)

Safer prescription of drugs: impact of the PREFASEG system to aid clinical decision-making in primary care in Catalonia
por: Pons-Mesquida, M. Àngels, et al.
Publicado: (2021)

Impact of a system to assist in clinical decision-making in primary healthcare in Catalonia: prescription Self Audit
por: Pons-Mesquida, M. Àngels, et al.
Publicado: (2022)

Oxycodone/Naloxone: Role in Chronic Pain Management, Opioid-Induced Constipation, and Abuse Deterrence
por: DePriest, Anne Z., et al.
Publicado: (2014)

Assessment of Neurotoxic Effects of Oxycodone and Naloxone in SH-SY5Y Cell Line
por: Lima, Luíza Siqueira, et al.
Publicado: (2023)

Effectiveness of early detection on breast cancer mortality reduction in Catalonia (Spain)
por: Rue, Montserrat, et al.
Publicado: (2009)

Epidemiology of Echovirus 30 Infections Detected in a University Hospital in Catalonia, Spain, in 1995–2020
por: del Cuerpo, Margarita, et al.
Publicado: (2022)

Efficacy and tolerability balance of oxycodone/naloxone and tapentadol in chronic low back pain with a neuropathic component: a blinded end point analysis of randomly selected routine data from 12-week prospective open-label observations
por: Ueberall, Michael A, et al.
Publicado: (2016)

Seroprevalence of Bartonella spp. infection in HIV patients in Catalonia, Spain
por: Pons, Immaculada, et al.
Publicado: (2008)

Incidence and clinical features of kawasaki disease in Catalonia (Spain)
por: Sanchez-Manubens, Judith, et al.
Publicado: (2014)

Cost-effectiveness of early detection of breast cancer in Catalonia (Spain)
por: Carles, Misericordia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_opevmij3s1h3irrpf8ocs0fscc